NEW YORK, Oct. 4, 2023 /PRNewswire/ — The light therapy market is expected to grow by USD 246.87 million from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 4.72% during the forecast period, according to Technavio Research. The market has been segmented by end-user (commercial, domestic, and healthcare), type … Read more
NEW YORK, Oct. 3, 2023 /PRNewswire/ — Firmament, a provider of structured equity and debt capital solutions to small- and medium-sized enterprises, announced today an investment in Prime Providers (“Prime” or the “Company”), to support the Company’s acquisition of Right Choice In-Home Care (“Right Choice”). Prime is a home-based healthcare organization providing private duty nursing, … Read more
FAIRFIELD, N.J., 2 de octubre de 2023 /PRNewswire/ — Vela Diagnostics anunció hoy una colaboración de investigación con SRL Inc, una importante empresa japonesa de servicios de atención médica. Esta asociación tiene como objetivo facilitar la distribución de las soluciones de diagnóstico molecular de vanguardia de Vela Diagnostics en Japón. Establecida en 1970, SRL Inc … Read more
PEYNIER, France, 1er octobre 2023 /PRNewswire/ — La collaboration entre Leo Cancer Care et THERYQ réunit la vaste expertise des deux organisations pour créer une solution intégrée qui promet de révolutionner le traitement des tumeurs solides profondes. S’appuyant sur une technologie de pointe et une ingénierie de précision, cette collaboration vise à fournir aux radio-oncologues et … Read more
SHENZHEN, China, Sept. 30, 2023 /PRNewswire/ — The 59th Annual Meeting of the European Association for the Study of Diabetes (EASD) is set to take place from October 2nd to 6th, 2023, in Hamburg, Germany. Making its debut at this prestigious event, Shenzhen Sibionics Technology Co., Ltd. (hereinafter referred to as “SIBIONICS”) will unveil its flagship … Read more
TAIPEI, Taiwan, Sept. 30, 2023 /PRNewswire/ — Foresee Pharmaceuticals (TPEx: 6576), (“Foresee”) announced today that the company will present the clinical design of the FP-045 Phase 1/2 clinical Fanconi anemia clinical study (FuschiA study) currently being initiated, at the Fanconi Anemia Research Fund (FARF) 2023 Scientific Symposium taking place in Vancouver, BC, Canada from September … Read more
MIDDLETON, Wisc., Sept. 29, 2023 /PRNewswire/ — Leo Cancer Care’s revolutionary patient positioning system designed to deliver radiation therapy in a more ‘human way’ for cancer patients has taken a critical step towards 510(k) regulatory clearance. With the regulatory decision for the innovative system now pending, 510(k) clearance will mean the upright technology will have … Read more
NEW YORK, Sept. 28, 2023 /PRNewswire/ — In keeping with its deep commitment to serving locally and culturally relevant food at its client schools across the nation, Genuine Foods hosted its first ever “Genuine Loves” event in Fletcher, VT. Serving as a debut for this first-of-its kind national program, “Genuine Loves” takes school meals to a … Read more
The collaboration continues BCBSTX’s statewide expansion of Special Beginnings® to improve maternal and infant health outcomes in Texas RICHARDSON, Texas, Sept. 27, 2023 /PRNewswire/ — Health equity researchers at Bracane have begun hosting listening sessions to include community voices and experiences into Blue Cross and Blue Shield of Texas‘ (BCBSTX) expanded Special Beginnings® initiative aimed at improving … Read more
MELBOURNE, Australia and LIEGE, Belgium, Sept. 27, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) has welcomed Her Royal Highness, Princess Astrid, Princess of Belgium to Telix Manufacturing Solutions (TMS), the Company’s recently inaugurated production facility, in Brussels South (Seneffe) in the Wallonia region of Belgium. Located in the heart of Belgium’s ‘Radiopharma … Read more